Preventive effects of protopanaxadiol and protopanaxatriol ginsenosides on liver inflammation and apoptosis in hyperlipidemic apoE KO mice. 2012

Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
Department of Food and Nutrition, Nutrition Biochem Lab, Sungshin Women's University, #249-1, 3-ga, Dongsun-dong, Sungbuk-ku, Seoul, 136-742, Republic of Korea.

Ginsenosides, bioactive compounds of Panax Ginseng C.A. Meyer, are divided into protopanaxadiol (PD) and protopanaxtriol (PT). The aim of this study was to evaluate the protective effects of different PD and PT combination ratios on liver inflammation and apoptosis in hyperlipidemic apo E KO mice. R1 (PD/PT = 1, high Rg(1) and Rb(1)) and R2 (PD/PT = 2, high Re and Rd) extracts were intraperitoneally injected by 100 mg/kg/day at the 8th week. R1 and R2 improved atherogenic indices by increasing HDL and lowering total cholesterol (TC) and triacylglyceride (TG) selectively. R1 decreased lipid peroxides (LPO) level in plasma and liver tissue of hyperlipidemic mice, and R2 lowered plasma malondialdehyde(MDA) level. R1 and R2 not only regulated the expression of cyclooxygenase (COX)-2, IκB-α, phopho-ERK 1/2, and phopho-SAPK/JNK levels but also were significantly effective in blocking apoptotic signals, such as caspase-8, -9, as well as the cleavage of PARP in liver. Different combinational treatment of PD and PT extracts might ameliorate the liver inflammation and apoptosis in hyperlipidemic apo E KO mice, which is atherosclerotic animal model.

UI MeSH Term Description Entries

Related Publications

Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
January 2016, Evidence-based complementary and alternative medicine : eCAM,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
June 2019, RSC advances,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
January 2024, Journal of ethnopharmacology,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
May 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
January 2015, Biological & pharmaceutical bulletin,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
January 2015, Biological & pharmaceutical bulletin,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
January 2007, Vaccine,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
January 2009, Atherosclerosis,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
July 2013, Biomedical reports,
Soojeong Jang, and Yunsook Lim, and Giuseppe Valacchi, and Sungbin Sorn, and Hyon Park, and Na-Young Park, and Myoungsook Lee
May 2022, ACS omega,
Copied contents to your clipboard!